PRVA
Undervalued by 59.6% based on the discounted cash flow analysis.
Market cap | $2.66 Billion |
---|---|
Enterprise Value | $2.20 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.12 |
Beta | 0.83 |
Outstanding Shares | 120,623,670 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 168.72 |
---|---|
PEG | 407.34 |
Price to Sales | 1.57 |
Price to Book Ratio | 4.4 |
Enterprise Value to Revenue | 1.22 |
Enterprise Value to EBIT | 95.25 |
Enterprise Value to Net Income | 140 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.01 |
No data
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...